Control of cell cycle regulatory proteins and modulation of STAT1 proteins by IFN-gamma in human prostatic JCA-1

M Oya1, S Konno, Y Chen

  • 1NEW YORK MED COLL,DEPT BIOCHEM & MOL BIOL,VALHALLA,NY 10595. NEW YORK MED COLL,DEPT UROL,VALHALLA,NY 10595.

Insights

Human recombinant interferon-gamma (IFN-gamma) significantly inhibits prostate cancer cell growth by altering cell cycle regulation. IFN-gamma affects key proteins controlling cell cycle progression and activates STAT1 alpha, contributing to its antiproliferative effects.

Area of Science:

  • Oncology
  • Cell Biology
  • Immunology

Background:

  • Prostate cancer remains a significant health concern.
  • Interferon-gamma (IFN-gamma) is a cytokine with known immunomodulatory and antiproliferative properties.
  • Understanding the molecular mechanisms of IFN-gamma's effects on prostate cancer cells is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the antiproliferative effects of human recombinant IFN-gamma on JCA-1 human prostate cancer cells.
  • To elucidate the impact of IFN-gamma on cell cycle progression and the expression of related regulatory proteins.

Main Methods:

  • Cell growth inhibition assays using JCA-1 cells treated with varying doses of IFN-gamma.
  • Cell cycle phase analysis (G1 and G2/M) following IFN-gamma treatment.
  • Western blot analysis to assess the expression levels of cell cycle regulatory proteins (cyclins, CDKs, CDKIs) and STAT1 alpha.

Main Results:

  • IFN-gamma inhibited JCA-1 cell growth in a dose-dependent manner (27% at 10^2 IU/ml, 64% at 10^3 IU/ml).
  • High-dose IFN-gamma treatment led to G1 cell cycle arrest and decreased G2/M phase.
  • IFN-gamma modulated cell cycle proteins, downregulating G1/S transition molecules (cyclin D1, Cdk4, pRB) and upregulating G2/M transition molecules (cyclin B1, p34(cdc2)).
  • IFN-gamma induced p53 expression and inhibited p21(WAF1) at higher doses.
  • IFN-gamma increased and sustained STAT1 alpha expression.

Conclusions:

  • IFN-gamma exhibits significant antiproliferative effects on human prostate cancer cells.
  • The antiproliferative action of IFN-gamma involves complex modulation of cell cycle regulatory proteins.
  • Activation of STAT1 alpha and alterations in cell cycle checkpoints likely contribute to IFN-gamma's therapeutic potential in prostate cancer.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System02:11

The Cell Cycle Control System

The cell cycle is an organized set of events that leads the cell to divide into two daughter cells, each containing chromosomes identical to the parent cell. It is the cell cycle that leads to the formation of an entire organism from a single-cell zygote. Besides, cell division also functions in the renewal or repair of tissues in adult multicellular eukaryotes. For example, in the bone marrow, the stem cells divide to form new blood cells. Although essential for several functions, cell...